Unlock stock picks and a broker-level newsfeed that powers Wall Street.

BSE - Delayed Quote INR

Alkali Metals Limited (ALKALI.BO)

83.80
-1.86
(-2.17%)
At close: April 30 at 3:29:23 PM GMT+5:30
Loading Chart for ALKALI.BO
  • Previous Close 85.66
  • Open 85.79
  • Bid 83.60 x --
  • Ask 87.80 x --
  • Day's Range 83.60 - 86.18
  • 52 Week Range 75.26 - 165.00
  • Volume 2,680
  • Avg. Volume 3,203
  • Market Cap (intraday) 853.294M
  • Beta (5Y Monthly) 0.52
  • PE Ratio (TTM) --
  • EPS (TTM) -8.90
  • Earnings Date May 23, 2025 - May 27, 2025
  • Forward Dividend & Yield 1.00 (1.19%)
  • Ex-Dividend Date Aug 16, 2024
  • 1y Target Est --

Alkali Metals Limited manufactures and sells chemicals in India and internationally. The company offers API products, including benzocaine, fluconazole, loperamide hydrochloride, losartan potassium, metformin hydrochloride, phenylephrine hydrochloride, and rabeprazole sodium. It also provides pyridine, acetylpyridine, alkyl borate, aminopyridine, bipyridine, bromopyridine, chloropyridine, cyanopyridine, cyclic, diethylamino pyridine, ethoxypyridine, fluoropyridine, hydroxypyridine, methoxypyridine, nitropyridine, picolylalcohol, pyridine n-oxide, pyrimidine, tetrazole, and triazole compounds; azaindole, potassium, sodium, and other metal derivatives; and boronic acids, fine chemicals, and DSSC and OLED materials. The company's products are used in pharma intermediates, anti retrovirals, flu vaccines, antibiotics, cardio/anti inflammation, agrochemicals, and automobiles applications. Alkali Metals Limited was incorporated in 1968 and is based in Hyderabad, India.

www.alkalimetals.com

107

Full Time Employees

March 31

Fiscal Year Ends

Recent News: ALKALI.BO

View More

Performance Overview: ALKALI.BO

Trailing total returns as of 4/30/2025, which may include dividends or other distributions. Benchmark is S&P BSE SENSEX (^BSESN) .

YTD Return

ALKALI.BO
24.98%
S&P BSE SENSEX (^BSESN)
2.69%

1-Year Return

ALKALI.BO
25.96%
S&P BSE SENSEX (^BSESN)
7.73%

3-Year Return

ALKALI.BO
7.17%
S&P BSE SENSEX (^BSESN)
40.63%

5-Year Return

ALKALI.BO
90.60%
S&P BSE SENSEX (^BSESN)
137.98%

Compare To: ALKALI.BO

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: ALKALI.BO

View More

Valuation Measures

Annual
As of 4/30/2025
  • Market Cap

    853.29M

  • Enterprise Value

    1.07B

  • Trailing P/E

    --

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    1.05

  • Price/Book (mrq)

    1.90

  • Enterprise Value/Revenue

    1.32

  • Enterprise Value/EBITDA

    --

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    -11.72%

  • Return on Assets (ttm)

    --

  • Return on Equity (ttm)

    --

  • Revenue (ttm)

    818.8M

  • Net Income Avi to Common (ttm)

    -95.99M

  • Diluted EPS (ttm)

    -8.90

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    --

  • Total Debt/Equity (mrq)

    --

  • Levered Free Cash Flow (ttm)

    --

Research Analysis: ALKALI.BO

View More

Company Insights: ALKALI.BO

Research Reports: ALKALI.BO

View More

People Also Watch

Waiting for permission
Allow microphone access to enable voice search

Try again.